Trial Profile
Telbivudine to prevent mother-to-infant transmission of HBV in early and mid pregnancy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2017
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 28 Apr 2016 New trial record